Business

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Operational Highlights

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year ...

articleOncolytics Biotech Inc.February 26, 20213/company/oncolytics-biotech-inc/news/oncolytics-biotechandxae-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-financial-results-and-operational-highlights
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Operational Highlights

About this update from Oncolytics Biotech Inc.

[{"type":"text","content":"\n \n \n \n Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Operational Highlights\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP-COLOR:; VERTICAL-ALIGN: BOTTOM; BORDER-LEFT-COLOR:; BORDER-BOTTOM-COLOR:; PADDING-LEFT:0.50em; BORDER-RIGHT-COLOR:; PADDING-RIGHT:0.50em\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n.prntal{\nTEXT-ALIGN: LEFT\n}\n \n \n \n \n \n \n Conference call and webcast to take place on Friday, March 5, 2021 at 8:30 am ET\n \n \n Canada NewsWire\n \n \n \n \n \n SAN DIEGO, Calif.\n \n and\n \n CALGARY, AB\n \n ,\n \n Feb. 26, 2021\n \n /CNW/ -- Oncolytics Biotech\n \n ®\n \n Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on\n \n Friday, March 5, 2021\n \n , at\n \n 8:30 am ET\n \n to discuss a corporate update and financial results for the fourth quarter and full year 2020.\n \n \n \n \n Conference Call & Webcast\n \n \n \n \n \n Date:\n \n Friday, March 5, 2021\n \n \n Time:\n \n 8:30 am ET\n \n \n Dial In – North American Toll-Free:\n \n (888) 231-8191\n \n \n Dial In – International:\n \n (647) 427-7450\n \n \n Conference ID\n \n (if needed)\n \n :\n \n 569-6653\n \n \n Webcast:\n \n please click\n \n here\n \n \n \n A live webcast of the call will also be available on the Investor Relations page of Oncolytics' website, available by clicking\n \n here\n \n and will be archived for three months. A dial in replay will be available for one week and can be accessed by dialing (855) 859-2056 (\n \n North America\n \n ) or (416) 849-0833 (International) and using reference code: 569-6653.\n \n \n \n About Oncolytics Biotech Inc.\n \n \n Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immuno-oncolytic virus. The compound induces selective tumor lysis and promotes an inflamed tumor phenotype -- turning \"cold\" tumors \"hot\" -- through innate and adaptive immune responses to treat a variety of canc...

More updates from Oncolytics Biotech Inc.